Saiz A., Arpa J., Sagasta A. et al. Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset insulin-dependent diabetes mellitus, and polyendocrine autoimmunity // Neurology. - 1997. - Vol. 49, № 4. - P. - 1026-1030.
Schimmel M., Bien C.G., Vincent A. et al. Successful treatment of anti-N-methyl-D-aspartate receptor encephalitis presenting with catatonia // Arch. Dis. Child. – 2009. – Vol. 94, № 4. – P 314-316.
Schröder A., Linker R.A., Gold R. // Plasmapheresis for neurologic disorders. – 2009. – Vol. 9, № 9. – P. 1331-1339.
Sevy A., Doche E., Squarcioni C. et al. Stroke in a young patient treated by alteplase heralding an acquired thrombotic thrombocytopenic purpura // J. Clin. Apher. – 2011. – Vol. 26, № 3. – P. 152-155.
Shariatmadar S., Noto T.A. Plasma exchange in stiff-man syndrome // Ther. Apher. – 2001. – Vol. 5, № 1. – P. 74-67.
Shinozaki K., Oda S., Sadahiro T. et al. A case report of plasmapheresis in the treatment of acute disseminated encephalomyelitis // Ther. Apher. Dial. – 2008. – Vol. 12, № 5. – P. 401-405.
Sinha S., Newsom-Devis J., Mills K. et al. Autoimmune aetiology for acquired neuromyotonia (Isaacs’ syndrome) // Lancet. - 1991. - Vol. 338, № 8758. - P. 75-77.
Smith R.G., Siklos L., Alexianu M.E. et al. Autoimmunity and ALS // Neurology. - 1996. - Vol. 47, № 4, Suppl. 2. - P. S40-S46.
Soria A., Maubec E., Henry-Feugeas M.C. et al. [Panniculitis induced by interferon beta-a] // Ann. Dermatol. Venerol. – 2007. – Vol. 134, № 4 Pt 1. – P. 374-377.
Sriram S., Rodrigues M. Indictment of the microglia as the villain in multiple sclerosis // Neurology. - 1997. - Vol. 48, № 2. - P. 464-470.
Staines D.R. Is Parkinson’s disease an autoimmune disorder of endogenous vasoactive neuropeptides? // Med. Hypotheses. – 2007. – Vol. 69, № 6. – P. 1208-1211.
Staines D.R., Brenu E.W., Marshall-Gradisnik S. Postulated role of vasoactive neuropeptide-related immunopathology of the blood brain barrier and Vircov-Robin spaces in aetiology of neurological-related conditions // Mediators Inflamm. – 2008; 2008:792428.
Straub J., Chofflon M., Delavelle J. Early high-dose intravenous methylprednisolone in acute disseminated encephalomyelitis: A successful recovery // Neurology. - 1997. - Vol. 49, № 4. - P. 1145-1147.
Tan I.L., McArthur J.C., Clifford D.B. et al. Immune reconstitution inflammatory syndrome in natalizumab-associated PML // Neurology. – 2011. – Vol. 77, № 11. – P. 1061-1067.
Tanne D., D’Olhaberriague L., Schultz L.R. et al. Anticardiolipin antibodies and their associations with cerebrovascular risk factors // Neurology. – 1999. – Vol. 52, № 7. – P. 1368-1373.
Terai K., Walker D.G., McGeer E.G., McGeer P.L. Neurons express proteins of the classical complement pathway in Alzheimer disease // Brain Res. - 1997. - Vol. 769, № 2. - P. 385-390.
Tharakan J., Jayapraksh P.A., Iyer V.P. Small volume plasma exchange in Guillain-Barre syndrome: experience in 25 patients // J. Assoc. Physicians India. – 1990. – Vol. 38, № 8. – P. 550-553.
The French Cooperative Group on Plasma Exchange in Guillain-Barré Syndrome. Appropriate number of plasma exchanges in Guillain-Barré Syndrome // Ann. Neurol. - 1997. - Vol. 41, № 3. - P. 299-306.
Tietjen G.E., Day M., Norris L. et al. Role of anticardiolipin antibodies in young persons with migraine and transient focal neurologic events // Neurology. - 1998. - Vol. 50, № 5. - P. 1433-1440.
Tranchant C. Therapeutic strategy in myasthenia gravis // Rev. Neurol. (Paris). – 2009. – V0l. 165, № 2. – P. 149-154.
Trebst C., Reising A., Kielstein J.T. et al. Plasma exchange therapy in steroid-unresponsive relapses in patients with multiple sclerosis // Blood Purif. – 2009. – V0l. 28, № 2. – P. 108-115.
Tuomi T., Björses P., Falorni A. et al. Antibodies to glutamic acid decarboxilase and insulin-dependent diabetes in patients with autoimmune polyendocrine syndrome typ I // J. Clin. Endocrin. Metab. - 1999. - Vol. 81, № 4. - P. 1488-1494.
Uchihara T., Akiyama H., Kondo H., Ikeda K. Activated microglial cells are colocalized with perivascular deposits of amyloid- protein in Alzheimer’s disease brain // Stroke. 1997. - Vol. 28, № 10. - P. - 1948-1950.
Ueda T., Kanda F., Kobessho H. et al. “Droped head syndrome” caused by Lambert-Eaton myasthenic syndrome // Muscle Nerve. – 2009. – Vol. 40, № 1. – P. 134-136.
Valbonesi M., Bo A., De Luidgi M.C. et al. Cascade filtration (CF) with the Haemonetics MCS+: a new technical adaptation // Int. J. Artif. Organs. – 2001. – Vol. 24, № 3. – P. 164-166.
Van Boxel-Dezaire A.H.H., Hoff S.C.J., van Oosten B.W. et al. Decreased interleukin-10 and increased interleukin-12p40 mPNA are associated with disease activity and characterize different discase stages in miltiple sclerosis // Ann. Neurol. – 1999. – Vol. 45, № 6. – P. 695-703.
Wang K.C., Wang S.J., Lee C.L. et al. The rescue effect of plasma exchange for neuromyelitis optica // J. Clin. Neurosci. – 2011. – Vol. 18, № 1. – 43-46.
Watanabe S., Nakashima I., Misu T. et al. Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica // Mult. Scler. – 2007. – Vol. 13, № 1. – P. 128-132.
Weinshenker B.G. Plasma exchange for acute attacks of demyelinating disease: detecting a Lazarus effect // Ther. Apher. – 2000. – Vol 4, № 3. – P. 187-189.
Winters J.L., Brown D., Hazard E. et al. Cost-minimization analysis of the direct costs of TPE and IVIg in the treatment of Guillain-Barré syndrome // BMC Health. Serv. Res. – 2011. – № 11. – P. 101.
Yaar M., Zhai S., Pilch P.F. et al. Binding of -amyloid to the p75 neurotropin receptor induces apoptosis. A possible mechanism for Alzheimer’s disease // J. Clin. Invest. - 1997. - Vol. 100, № 9. - P. 2330-2340.
Yan S.D., Fu J., Chen X. et al. An intracellular protein that binds amyloid- peptide and mediates neurotoxicity in Alzheimer’s disease // Nature. - 1997. - Vol. 389, № 6652. - P. - 689-695.
Yeh J.H., Chiu H.C. Comparison between double-filtration plasmapheresis and immunoadsorption plasmapheresis in the treatment of patients with myasthenia gravis // J. Neurol. – 2000. – Vol. 247, № 7. – P. 510-513.
Yeh J.H., Chen W.H., Chiu H.C. Double filtration plasmapheresis in the treatment of myasthenic crisis – analysis of prognostic factors and efficacy // Acta Neurol. Scand. – 2001. – Vol. 104, № 2. – P. 78-82.
Yeh J.H., Chen W.H., Chiu H.C. Predicting the course of myasthenic weakness following double failtration plasmapheresis // Acta Neurol. Scand. – 2003. – Vol. 108, № 3. – P. 174-178.
Yeh J.H., Chen W.H., Huang K.M., Chiu H.C. Prethymectomy plasmapheresis in myasthenia gravis // J. Clin. Apher. – 2005. - Vol. 20, № 4. – P. 217-221.
Yoshida H., Ando A., Sho K. et al. Anti-aquaporin-4 antibody-positive optic neuritis with double-filtration plasmapheresis // J. Ocul. Pharmacol. Ther. – 2010. – Vol. 26, № 4. – P. 381-385.
Yücesan C., Arslan O., Arat M. et al. Therapeutic plasma exchange in the treatment of neuroimmunologic disorders: review of 50 cases // Transfus. Apher. Sci. – 2008. Vol. 36, № 1. – P. 103-107.
Yuki N., Tagawa Y., Handa S. Autoantibodies to peripheral nerve glycosphingolipids SPG, SLPG, and SGPG in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy // J. Neuroimmunol. - 1996. - V. 70, № 1. - P. 1-6.
Yuki N., Koda M., Hirata K. Isolated internal ophthalmoplegia associated with immunoglobulin G anti-GQ1b antibody // Neurology. – 1998. – Vol. 51, № 5. – P. 1515-1516.
Yuki N. Fisher syndrome and Bickerstaff brainstem encephalitis (Fisher-Bickerstaff syndrome) // J. Neuroimmunol. – 2009. – Vol. 215, № 1-2. – P. 1-9.
Zarkou S., Carter J.L., Wellik K.E. et al. Are corticosteroids efficacious for preventing or treating neutralizing antibodies in multiple sclerosis patients treated with beta-interferons? A critically appraised topic // Neurologist. – 2010. – Vol. 16, № 3. – P. 212-214.
Zisimopoulou P., Lagoumintzis G., Kostelidou K. et al. Towards antigen-specific apheresis of pathogenic autoantibodies as a further step in the treatment of myasthenia gravis by plasmapheresis // J. Neuroimmunol. – 2008. – Vol. 15, 201-202. – P. 95-103.